REXAHN PHARMACEUTICALS INC 10-Q 6-30-2013

Company

Opus Genetics, Inc.

Filed

August 12, 2013

Period of Report

June 30, 2013

Accession Number

0001140361-13-031714

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →